Approval · Notice of Compliance 10660 · 2009
SUPPRESSOR: Notice of Compliance 10660
Issued October 14, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10660
- Date
- October 14, 2009
- Company
- Norbrook Laboratories Ltd.Newry, Northern Ireland, United Kingdom
- Product type
- Veterinary
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Additional claims
- Therapeutic class
- Anti-inflammatory, analgesic, antipyretic
- Canadian reference product
- BANAMINE (Intervet Canada Corp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUPPRESSOR | 02248807 | Cancelled Post Market |
Medicinal ingredients
- FLUNIXIN MEGLUMINE 50 MG per ML